Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters, 5th Edition
This guideline discusses the necessary and recommended data for selecting appropriate breakpoints and quality control ranges for antimicrobial agents.
Supplemental information for M23 is published in CLSI document M23S.
This document is available in electronic format only.
Chairholder: Matthew A. Wikler, MD, MBA, FIDSA
Date of Publication: January 16, 2018
Order Code PDF: M23Ed5E
ISBN Number: 1-56238-843-6
Order Code Print: print not available
M23 Additional Details
If interested in ordering larger quantities of this document in print, please contact us here.